Generic competition to Topamax and Risperdal cut into sales, but strong growth from inflammatory disease treatment Remicade helped moderate the damage.
The National Institute of Alcohol Abuse and Alcoholism is watching new human trials of the antiseizure drug topiramate (Topamax) to study the effectiveness of dual treatment for alcohol and cocaine addiction.